title: Treatment of metastatic medullary thyroid cancer with vandetanib: need to stratify patients on basis of calcitonin doubling time.
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Chatal
authors.forename: Françoise
authors.initials: F
authors.lastname: Kraeber-Bodéré
authors.forename: David M
authors.initials: DM
authors.lastname: Goldenberg
authors.forename: Jacques
authors.initials: J
authors.lastname: Barbet
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D010880:Piperidines / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D013964:Thyroid Neoplasms / Q000188:drug therapy*
chemical_list: D010880:Piperidines; D011799:Quinazolines